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Abstract  
Currently HIV infected men and women are living longer quality lives. This 
phenomenon is raising more and more ethical questions concerning ability to 
reproduce offspring. HIV infected women frequently ask health care providers 
about the safety and risks of becoming pregnant. HIV infected women also face the 
challenges of fertility more frequently and seek assisted reproductive technologies. 
Each case raises many ethical questions. The case study discussed in this paper 
illustrates the ethical issues raised by knowingly risking the birth of a child, as well 
as the health of the woman infected with HIV. The paper also offers a more 
balanced approach to enable nurses to understand the issues. 
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The Ethics of Assisted Reproduction Technologies 
and the HIV Infected Woman 
 
INTRODUCTION 
In the United States, 25 percent of all newly acquired immune deficiency syndrome 
(AIDS) cases and 35 percent of human immunodeficiency virus (HIV-1) infections occur 
in women (CDC, 2001). Women represent the subgroup with the fastest rate of increase 
in HIV infection. The majority of these women are of reproductive age, and many of the 
risk factors linked to HIV infection (e.g., unsafe sexual activities) may also predispose 
women to infertility (Lindegreen, et al., 1999). Since the early years of the HIV epidemic, 
the treatment of infertility in HIV-infected women, as well as couples, has remained 
highly controversial. The possibility of mother-to-child transmission of HIV and the 
likelihood that the mother will die before her child reaches complete independence are 
among the issues faced by health care providers treating HIV positive women seeking 
artificial reproductive technologies (ART). The use of highly active antiretroviral therapy 
and protocols for the reduction of the risk of mother-to-child transmission of HIV evoke 
continued critical ethical considerations in the treatment of infertility in women with HIV 
infection. 
The risk of HIV transmission to offspring can be greatly reduced but not eliminated. This 
risk raises ethical issues concerning the scope of freedom to reproduce (autonomy), 
what can be considered harm (fetal beneficence) sufficient to justify restricting that 
freedom, and the responsibilities (duty) of health care professionals faced with a request 
to provide ART services to HIV infected patients. The following is a case study to 
illustrate the ethical issues raised by knowingly risking the birth of a child with HIV. 
Case Information 
The patient is a 26-year-old female with HIV infection. She presented to an advanced 
practice nurse with request for assistance with infertility treatment. She reported that 
she has been having unprotected intercourse for 18 months without achieving 
pregnancy with her significant other, also HIV positive. She also reported strict 
adherence to her antiretroviral regimen as well as undetectable viral status for herself 
(<50 copies) and near undetectable viral status for her significant other (598 copies). 
Past Medical History 
The patient tested positive for HIV in 1999 at a local health fair offering free testing. Her 
CD4 count was 279/mm3 with a viral load of greater than 750,000 copies. She started 
taking zidovudine/ lamivudine (Combivir, GlaxoSmith Klein), one tablet twice daily and 
nelfinavir (Viracept, Agouron) 250mg, five tablets twice daily, to treat her HIV disease. 
She had an excellent virologic response to her antiretroviral regimen that resulted in a 
CD4 count of 525/mm3 and a viral load that was less than 400 copies within eight 
weeks. Menses are stated as regular by the patient. No other significant medical history 
was noted. No surgical history was noted. 
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Family History  
Mother: Alive and well; hyperlipidemia, surgical menopause at age 51, G4P4004 
Father: Alive and well; HTN, CHF 
Siblings: Alive and well; no known comorbidities 
Social History  
The patient has been employed as a sales clerk in a local retail store for three years. 
Her significant other works as a car dealer. They live together in a three-bedroom 
house. There is no history of injection drug use or tobacco abuse. The patient drinks 
alcohol on rare social occasions. 
Sexual History 
G1P1001 , menarche: age 13. First intercourse: age 15. Number of lifetime partners: 20+. 
Denies history of anal intercourse. Positive for history of rape at age 15 by older, known 
family member. Last menstrual period: 15 days ago, regular. 
Current Medications 
No Known Drug Allergies 
Zidovudine/ lamivudine (Combivir): one tablet twice daily 
Nelfinavir (Viracept): 250mg, five tablets twice daily 
Multivitamin one tablet daily 
Laboratory values at Initial Office Visit 
HIV viral load: <50 copies/ ml 
CD4+: 789/mm3 
Assessment 
S: 26 yo HIV+ female desiring ART 
O: WNL 
A: Tubal infertility 
P: Should the patient be offered ART? 
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The Issues 
A consensus is emerging that ART should be offered to some couples in which one or 
both partners are infected with HIV. More ethical and scientific literature states there is 
now an ethical obligation to provide ART to such couples, consistent with respect for 
both autonomy and beneficence (Anderson, 1999; Minkoff & Santoro, 2000). Those who 
support providing these services to this population cite three major reasons. First, 
therapeutic improvements in the management of HIV infection have enhanced both 
quality and length of life for HIV-positive individuals. Second, advances in prenatal 
therapy have substantially reduced the risk of mother-to-infant HIV transmission. Third, 
current ART methods will reduce transmission of HIV from an infected partner to an 
uninfected partner (Anderson; 1999, Ethics Committee of the American Society for 
Reproductive Medicine, 2002; Minkoff & Santoro, 2000). 
Those who oppose offering ART to HIV-infected couples cite two major objections: 
uncertain long-term parental prognosis, and the continuing risk of maternal-to-fetal HIV 
transmission. The ethical underpinning of this opposition is that the best interest of the 
child to be born to a parent who may not be available for continuing childrearing is at 
stake. In addition, the risk of maternal to child transmission places the child at risk of 
acquiring a highly debilitating illness (Dubler & Levine, 1990).  
Health care providers should keep in mind that an ethical debate supports two 
seemingly correct answers. Clinical ethics provide a structured approach for identifying, 
analyzing, and resolving both sides of the issue. The practice of good clinical health 
care requires a working knowledge about ethical issues, such as confidentiality, patient 
rights, truth telling and informed consent. It also is necessary that while philosophically 
studying the morality of the debate each of the issues, problems, and judgments are 
open for individual interpretation. This individual interpretation imposes increased 
difficulty in removing one’s own moral issues from the debate and focusing on the 
debates ethical attributes. Clinical ethics relies on the certainty that, even when 
perplexity is great and emotions strong, health care providers, patients and their families 
can work constructively to identify, analyze, and resolve many of the ethical problems 
that appear in the clinic arena. 
Practitioner Responsibilities 
Prima facie duty is defined as a conditional duty always acted on unless it conflicts on a 
particular occasion with a more stringent duty (Arras, 1999). Today a health care 
provider’s ethical duty is to accept a patient or to continue to care for a person who is 
HIV-positive and to not discriminate against those who choose to reproduce, even 
though it may be against the provider’s moral standards (Annas, 1998). If the provider 
believes that in view of residual risk to the child and the mothers uncertain future, he or 
she does not wish to help the patient, his/her duty is to direct them to another provider 
who may be able to help them. The duty of the health care provider who counsels HIV 
positive patients is to fully inform them of the potential risks of transmission and 
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recommend the safest procedures for conception and delivery. This counseling includes 
discussion concerning administration of antiretroviral drugs to the HIV positive woman 
during the second and third trimesters of her pregnancy and to her baby during its first 
six weeks of life to limit the risk of mother-to-child HIV transmission to <1% (DHHS, 
2003). Couples should also be advised that the absolute safest courses to consider are 
adoption, child-free living, or (if the male is HIV-positive) donor sperm. 
Health care providers also have a duty to fully inform couples about risks incurred by 
the child such as vertical transmission of HIV from the mother, potential drug toxicities, 
unknown effects of drugs and/ or virus on long-term development of the child (Ethics 
Committee, 2002). Finally, attention must be drawn to uncertainties regarding the 
mother’s future health due to her HIV infection. The aim is to provide full, clear and 
factual information enabling the couple to make an enlightened and autonomous 
decision. 
Ethical Principles 
Autonomy derives from the Greek autos (self) and nomon (rule or governance) and 
literally means self-rule (Pickett, 2001). In health care practice, the principle of 
autonomy implies personal rule of the self that is free both from controlling interferences 
by others and from personal limitations that prevent meaningful choice, such as 
inadequate understanding (Beauchamp & Childress, 2001). Respect for a patient’s 
autonomy acknowledges a person’s right to hold views, to make choices, and to take 
actions based on personal values and beliefs. Couples who are at risk for having other 
potentially life-threatening conditions that may affect them physically by conceiving or 
affect the outcome of the unborn child are not as scrutinized as HIV positive individuals. 
Treatment for ART is offered to other individuals with other illnesses such as cancer or 
heart disease or brittle diabetics. People who have genetic illnesses or who are at high 
risk for producing offspring with genetic illnesses are not condemned for the choice of 
parenthood. The right for reproductive choice comes from the principle of autonomy, 
whereas bringing about the birth of a child with a genetic disease has been considered 
as causing harm by some (Macer, 1990). Couples do not forego parenthood only 
because they are at high risk for producing a child that will have sickle cell disease, 
Down Syndrome, or cystic fibrosis, for example. Couples who conceive naturally do not 
have to justify their desire to have children. Maternal age is another risk factor that 
places offspring at risk although in most cases is overlooked by society. Being HIV 
positive does not mean that having an ill child is any worse than couples having an ill 
child from cystic fibrosis, sickle cell, or Down Syndrome. Unless however, the health 
care provider or society is allowing morality to overcome ethics. Autonomy provides a 
strong moral foundation for informed consent, in which a patient, fully informed about 
her medical condition and the available therapies, freely chooses to be a willing 
participant in any treatment or non-treatment (Mappes, 2001). Respect for patient 
autonomy, like all ethical principles, cannot be regarded as absolute and may at times 
be in conflict with other principles or other moral considerations. This health care 
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providers regards must allow for the patients autonomy and decision to conceive a child 
and reach a balance with fetal beneficence. 
Beneficence, which means doing or producing good, is the obligation to promote the 
well-being of others (Pickett, 2001). In this case, the fetus must be considered in regard 
to the ethical principle of beneficence. Although the risk of vertical transmission of HIV 
infection from mother-to-child can be reduced in many ways, the risk cannot be 
completely avoided. Health care providers who evaluate the ethics of assisting such 
patients to have children must address the question of whether offspring born with HIV 
are harmed despite the preventive steps taken. The health care providers and parents 
must consider the child may be born with HIV. In situations in which a child could be 
born with a serious disease, one can argue that individuals are not acting unethically in 
proceeding with reproduction if all reasonable precautions are taken to prevent disease 
transmission. Similarly, one can argue that health care providers are not acting 
unethically if all reasonable precautions to limit the risk of transmission of HIV are taken. 
However, health care providers cannot ethically proceed with ART if the facilities lack 
the clinical and laboratory resources needed to effectively care for HIV-positive couples 
that wish to have a child (Ethics Committee, 2002). In such instances, the health care 
provider should refer couples to a center that has these resources. 
Finally, justice is the principle of rendering what is due to others (Pickett, 2001). Justice 
is the most complex of the ethical principles to be considered because justice deals with 
the health care provider’s obligation to render to a patient what is owed and with the 
provider’s role in the allocation of limited medical resources in the community. Justice is 
the obligation to treat equally those who are alike or similar according to whatever 
criteria are selected. The issue of justice raised in this case is similar in some respects 
to those in couples who know they are carriers of an autosomal recessive disease, such 
as sickle cell anemia, Tay-Sachs disease or cystic fibrosis. The risk of transmitting an 
autosomal recessive genetic disease cannot be reduced below 25 percent, whereas the 
risk of HIV transmission can be reduced to as low as <1 percent (Lindegreen, et al., 
1999). Health care providers who are willing to provide ART to couples whose offspring 
are irreducibly at risk for a serious genetic disease should find it ethically acceptable to 
treat HIV-positive individuals who are willing to take reasonable steps to minimize the 
risks of transmission. 
Case Review 
In this case, the advanced practice nurse examined her own moral regards and chose 
to be guided by ethical principles, thus choosing to assist the patient and continue 
further care as part of her duty. Information was provided to completely inform the 
patient of all risks of pregnancy and HIV, as well as all options of ART. Time was 
offered to the patient to allow for autonomy in decision-making. This patient reported 
complete adherence to taking her antiretroviral medication regimen. Her laboratory 
results indicated viral control (VL < 50 copies), as well as a healthy immune system 
(CD4+ 789/mm3). These values infer minimal (<1percent) risk of viral transmission from 
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mother-to-child as well as decreased risk for infection to the mother. Fortunately, a 
balance of patient autonomy and fetal beneficence could be established in this case. 
Based on the information provided to reduce viral transmission risks and allow for the 
promotion of fetal beneficence, as well as mother beneficence, the patient was allowed 
and capable of being autonomous in the decision making process of her pregnancy and 
care. The patient was then referred to an obstetrician who specializes in assisted 
reproduction. 
Conclusion 
Requests for ART by HIV-infected couples will most probably increase in the future. The 
consortium of infected individuals with stable illness and with or without infertility is 
growing. These individuals are becoming aware of the low risk of maternal-to-infant HIV 
transmission with appropriate treatment and are desirous of attempting to achieve 
pregnancy. 
Assisted reproductive technologies should not be denied to HIV-infected individuals 
solely on the basis of their positive serostatus. Offering these technologies to infected 
individuals is consistent with balancing respect for autonomy with fetal beneficence. 
This field is an emerging one and is changing rapidly. Patients should be cared for by 
providers who have current knowledge and expertise in this field. For this reason, 
nurses as well as other health care providers, need to educate themselves with the 
ethical considerations, the technologies involved, and the accompanying knowledge 
base needed to advocate for these patients. 
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